Research

Meet LCFA's Amazing Researchers

Meet these leading scientists focused on lung cancer research, new treatments, and enhancing the lives of those living with lung cancer.

  • Jaime L. Schneider, MD, PhD

    Thoracic Medical Oncology / Cancer Metabolism

    Understanding how alterations in cancer metabolism drive lung cancer development, progression, and resistance to targeted therapies.

    Jaime L Schneider MD PhD

  • Jared Mayers, MD, PhD

    Pulmonary, Critical Care, & Microbial Metabolism

    Investigating microbial metabolic contributions to cancer development and acute infections in the low biomass lung environment.

    Jared Mayer MD PhD

  • Zhen Zeng, PhD

    Oncology

    Mapping exactly where cancer-fighting cells are located within tumors

    Zhen Zeng headshot

  • Julie Wu, MD

    Staff Physician, Medical Oncology

    Precision oncology integrating evidence-based models into clinical practice to personalize treatment approaches

  • Aparna Sharma, DM

    Thoracic medical oncologist

    Genomic characterization of young onset lung adenocarcinoma

  • Jonathan Villena-Vargas, MD

    Thoracic Surgeon

    Characterizing T cell PD-1 response in the tumor-draining lymph nodes of early-stage NSCLC patients

  • Jarushka Naidoo, MRCPI

    Clinical/Translational Investigator

    Identifying novel biomarkers of response and toxicity to immunotherapy

  • Triparna Sen, PhD

    Cell and molecular biologist

    Novel therapies for small cell lung cancer (SCLC)

  • Jon Zugazagoitia, MD, PhD

    Thoracic Oncology

    Developing precision immunotherapy strategies to improve outcomes of patients with NSCLC

  • Vincent Lam, MD

    Translational researcher

    Characterize the immune microenvironment in ALK+ lung cancer

  • Adrian Sacher, MD

    Thoracic medical oncologist

    Identify novel biomarkers that identify patients who will not benefit from immunotherapy

  • Ramin Salehi-Rad, MD, PhD

    Pulmonologist/critical care physician

    Studying the effects of a novel lung cancer vaccine that uses modified cells from the patient’s own tumor